Maria Giovanna Trivieri

Dr. Trivieri obtained her MD and PhD from the University of Pisa and the University of Toronto. Initially, she studied the effects of taurine supplementation and calcium channel blockers in the setting of iron overload cardiomyopathy. Subsequently, she was involved in characterizing a cardiac specific transgenic mouse overexpressing an enzyme involved in the metabolism of thyroid hormone. The research that she conducted resulted in peer-reviewed publications and allowed her to gain expertise in various fields, from integrated physiology in rodents (Echocardiogram, Invasive Hemodynamics, Histopathology, Langhendorff preparation, Telemetry), to calcium imaging and finally molecular biology (Cell cultures, Western/Northern Blotting, Real-time PCR). In 2007, she resumed her clinical training and obtained Canadian and American Board Certifications in Internal Medicine and Cardiology. 

In 2014, she relocated to Mount Sinai to receive further training in advanced HF and Transplantation. Her clinical research centered on the infiltrative cardiomyopathies and in collaboration with the Translational and Molecular Imaging Institute directed by Dr. Z. Fayad’s lab, she was involved in landmark studies on the use of PET/MR for the assessment of cardiac amyloidosis, sarcoidosis and mitral valve diseases.

Her work has been supported by the T32, institutional KL2, the Career Development Award from the American Heart Association (AHA), the Bayer Pulmonary Hypertension Accelerated Award and the Department of Defense (DOD).